Si-Bone (SIBN) Gains from Investment Securities (2017 - 2018)
Si-Bone's (SIBN) quarterly Gains from Investment Securities came in at $145000.0 in Q4 2018, up 110.14% year-on-year from $69000.0 in Q4 2017, and down 68.27% quarter-over-quarter from $457000.0 in Q3 2018.
Si-Bone (SIBN) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Si-Bone's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $145000.0 for Q4 2018.
- On a quarterly basis, Gains from Investment Securities rose 110.14% year-over-year to $145000.0 in Q4 2018; TTM through Sep 2019 was $145000.0, a 80.67% decrease from a year earlier, with the FY2018 full-year figure at $826000.0, up 597.59% from the prior year.
- Gains from Investment Securities eased to $145000.0 in Q4 2018 per SIBN's latest filing, from $457000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $457000.0 in Q3 2018 and bottomed at $69000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 145,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Sep 30, 2018 | 457,000.00 |
| Sep 30, 2018 | 457,000.00 |
| Jun 30, 2018 | 145,000.00 |
| Jun 30, 2018 | 145,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Dec 31, 2017 | 69,000.00 |
| Dec 31, 2017 | 69,000.00 |